94 related articles for article (PubMed ID: 9887232)
1. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.
Shen Z; Belinson J; Morton RE; Xu Y; Xu Y
Gynecol Oncol; 1998 Dec; 71(3):364-8. PubMed ID: 9887232
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
Shen Z; Wu M; Elson P; Kennedy AW; Belinson J; Casey G; Xu Y
Gynecol Oncol; 2001 Oct; 83(1):25-30. PubMed ID: 11585410
[TBL] [Abstract][Full Text] [Related]
4. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
5. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Xu Y; Gaudette DC; Boynton JD; Frankel A; Fang XJ; Sharma A; Hurteau J; Casey G; Goodbody A; Mellors A
Clin Cancer Res; 1995 Oct; 1(10):1223-32. PubMed ID: 9815916
[TBL] [Abstract][Full Text] [Related]
7. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
[TBL] [Abstract][Full Text] [Related]
8. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
Furui T; LaPushin R; Mao M; Khan H; Watt SR; Watt MA; Lu Y; Fang X; Tsutsui S; Siddik ZH; Bast RC; Mills GB
Clin Cancer Res; 1999 Dec; 5(12):4308-18. PubMed ID: 10632375
[TBL] [Abstract][Full Text] [Related]
10. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
Park KS; Kim MK; Im DS; Bae YS
Biochem Pharmacol; 2007 Mar; 73(5):675-81. PubMed ID: 17161826
[TBL] [Abstract][Full Text] [Related]
11. Lysophospholipids activate ovarian and breast cancer cells.
Xu Y; Fang XJ; Casey G; Mills GB
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):933-40. PubMed ID: 7639713
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
Park KS; Lee HY; Lee SY; Kim MK; Kim SD; Kim JM; Yun J; Im DS; Bae YS
FEBS Lett; 2007 Sep; 581(23):4411-6. PubMed ID: 17719584
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
Sandmann G; Siess W; Essler M
Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; BrĂ¼nner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
16. Lysophospholipids are potential biomarkers of ovarian cancer.
Sutphen R; Xu Y; Wilbanks GD; Fiorica J; Grendys EC; LaPolla JP; Arango H; Hoffman MS; Martino M; Wakeley K; Griffin D; Blanco RW; Cantor AB; Xiao YJ; Krischer JP
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1185-91. PubMed ID: 15247129
[TBL] [Abstract][Full Text] [Related]
17. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
18. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
Imai A; Furui T; Tamaya T; Mills GB
J Clin Endocrinol Metab; 2000 Sep; 85(9):3370-5. PubMed ID: 10999836
[TBL] [Abstract][Full Text] [Related]
19. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
Tanyi JL; Hasegawa Y; Lapushin R; Morris AJ; Wolf JK; Berchuck A; Lu K; Smith DI; Kalli K; Hartmann LC; McCune K; Fishman D; Broaddus R; Cheng KW; Atkinson EN; Yamal JM; Bast RC; Felix EA; Newman RA; Mills GB
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3534-45. PubMed ID: 14506139
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells.
Lee MJ; Jeon ES; Lee JS; Cho M; Suh DS; Chang CL; Kim JH
J Cell Biochem; 2008 May; 104(2):499-510. PubMed ID: 18027882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]